A Trial of Tocilizumab in ALS Subjects

Clinical trial NCT02469896 · COMPLETED

Trial details

NCT number: NCT02469896
Sponsor: Barrow Neurological Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ALS Amyotrophic Lateral Sclerosis Lou Gehrig's Disease Motor Neuron Disease

Start date: 2015-11-01
Primary completion: 2018-07-11
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.